Market and sector getting hit again. HIV drug news on competitor GILD being superior today. Combination putting a beating on hit for now. Watching for an entry point this morning on weakness to long side.
sector and market beating to push for better price points. Patience here and buy the dips is strategy to build position or trade on the swings. Solid company and safe dividend with very good product pipeline. Yielding around 6.9% now which is safe and great for retirement accounts or otherwise.